Skip to main content
. 2021 Feb 3;12:776. doi: 10.1038/s41467-021-21037-2

Fig. 1. Construction and characterization of mRNA-RBD vaccine.

Fig. 1

a Schematic of the mRNA-RBD vaccine design. The SARS-CoV-2 mRNA encodes the signal peptide (SP), receptor-binding domain (RBD) from SARS-CoV-2 strain Wuhan/IVDC-HB-01/2019. b mRNA-RBD was transfected into HEK293T cells. RBD expression in the cell lysate and supernatant was analyzed by western blotting. c Particle size of LNPs by dynamic light scattering. d A representative cryo-electron microscopy image of a LNPs solution following mRNA encapsulation. Scale bar, 100 nm. e Zeta potential for LNPs at pH 4.0 and 7.4. For b and d, two independent experiments were carried out with similar results. For c and e, one representative result from three independent experiments is shown. Source data are provided as a Source Data file.